European Union: Patent

In this sixth alert in our weekly series on the EU Pharma Package, we focus on the proposals of the European Commission, European Parliament and Council of the EU for another topic with a highly debated scope and with diverging interpretations across EU Member States: the "Bolar" exemption.

A few months ago, Intel announced its ambitious plans to build a cutting-edge chip packaging centre in Poland

The Court can reject a new line of arguments pursuant to R. 9.2 RoP in a case where the issue has been raised from the outset and the new argument is based on completely different passages...